Epigenetic regulation of death-associated protein kinase expression in primary gastric cancers from Chinese patients

European Journal of Cancer Prevention

Volumn 21, Issue 3, 2012, Pages 241-246

  Ye, Mei ^a   Li, Dongqing ^b   Zhou, Feng ^a   Guo, Qiusha ^a   Xia, Bing ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

DAPK; epigenetics; gastric cancer; methylation

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; MESSENGER RNA;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CHINA; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 84859422253     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32834c9caa     Document Type: Article

References (32)

1. Chan AW, Chan MW, Lee TL, Nq EK, Leung WK, Lau JY, et al. (2005). Promoter hypermethylation of death-associated protein-kinase gene associated with advance stage gastric cancer. Oncol Rep 13:937-941.
2. Christoph F, Kempkensteffen C,Weikert S, Köllermann J, Krause H, Miller K, et al. (2006). Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer. Br J Cancer 95:1701-1707. (Pubitemid 44950797)
3. Correa P, Houghton J (2007). Carcinogenesis of Helicobacter pylori. Gastroenterology 133:659-672. (Pubitemid 47187360)
4. Crew KD, Neugut AI (2006). Epidemiology of gastric cancer. World J Gastroenterol 12:354-362. (Pubitemid 43329250)
5. Dansranjavin T, Möbius C, Tannapfel A, Bartels M, Wittekind C, Hauss J, Witzigmann H (2006). E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases. Oncol Rep 15:1125-1131.
6. Farinati F, Cardin R, Cassaro M, Bortolami M, Nitti D, Tieppo C, et al. (2008). Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. Eur J Cancer Prev 17:195-200. (Pubitemid 351549658)
7. Gozuacik D, Kimchi A (2006). DAPK protein family and cancer. Autophagy 2:74-79.
8. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell 100:57-70. (Pubitemid 30046295)
9. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB (1996). Methylationspecific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci 93:9821-9826. (Pubitemid 26296693)
10. Inbal B, Cohen O, Polak-Charcon S, Kopolovic J, Vadai E, Eisenbach L, Kimchi A (1997). DAP kinase links the control of apoptosis to metastasis. Nature 390:180-184. (Pubitemid 27507988)
11. Jones PA, Baylin SB (2002). The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428. (Pubitemid 34587077)
12. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG (2001). CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 61:2847-2851. (Pubitemid 32691923)
13. Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH, Kim JS (2003). Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol 163: 1551-1556. (Pubitemid 37175101)
14. Kang GH, Lee S, Kim JS, Jung HY (2003). Profile of aberrant CpG island methylation along multistep gastric carcinogenesis. Lab Invest 83:519-526. (Pubitemid 36457706)
15. Kato K, Iida S, Uetake H, Takagi Y, Yamashita T, Inokuchi M, et al. (2008). Methylated TMS1 and DAPK genes predict prognosis and response to chemotherapy in gastric cancer. Int J Cancer 122:603-608. (Pubitemid 350308952)
16. Kawaguchi K, Oda Y, Saito T, Yamamoto H, Takahira T, Tamiya S, et al. (2004). Death-associated protein kinase (DAP kinase) alteration in soft tissue leiomyosarcoma: promoter methylation or homozygous deletion is associated with a loss of DAP kinase expression. Hum Pathol 35:1266-1271. (Pubitemid 39361651)
17. Kim HC, Kim JC, Roh SA, Yu CS, Yook JH, Oh ST, et al. (2005). Aberrant CpG island methylation in early-onset sporadic gastric carcinoma. J Cancer Res Clin Oncol 131:733-740. (Pubitemid 41577950)
18. Kim WS, Son HJ, Park JO, Song SY, Park C (2003). Promoter methylation and down-regulation of DAPK is associated with gastric atrophy. Int J Mol Med 12:827-830.
19. Kogel D, Prehn JH, Scheidtmann KH (2001). The DAP kinase family of proapoptotic proteins: novel players in the apoptotic game. Bioessays 23: 352-358. (Pubitemid 32285760)
20. Kuester D, Dar AA, Moskaluk CC, Krueger S, Meyer F, Hartig R, et al. (2007). Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression. Neoplasia 9:236-245. (Pubitemid 46457240)
21. Lehmann U, Celikkaya G, Hasemeier B, Länger F, Kreipe H (2002). Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype. Cancer Res 62:6634-6638. (Pubitemid 35364131)
22. Lévy D, Plu-Bureau G, Decroix Y, Hugol D, Rostène W, Kimchi A, Gompel A (2004). Death-associated protein kinase loss of expression is a new marker for breast cancer prognosis. Clin Cancer Res 10:3124-3130. (Pubitemid 38619693)
23. Nuñez F, Bravo S, Cruzat F, Montecino M, De Ferrari GV (2011). Wnt/b-catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells. PLoS One 6:e18562.
24. Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, Chen SS, et al. (2007). Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129:879-890. (Pubitemid 46813150)
25. Satoh A, Toyota M, Itoh F, Kikuchi T, Obata T, Sasaki Y, et al. (2002). DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers. Br J Cancer 86: 1817-1823. (Pubitemid 34712929)
26. Schneider-Stock R, Kuester D, Ullrich O, Mittag F, Habold C, Boltze C, et al. (2006). Close localization of DAP-kinase positive tumour-associated macrophages and apoptotic colorectal cancer cells. J Pathol 209:95-105.
27. Simpson DJ, Clayton RN, Farrell WE (2002). Preferential loss of death associated protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion. Oncogene 21:1217-1224. (Pubitemid 34185238)
28. Stevens C, Lin Y, Sanchez M, Amin E, Copson E,White H, et al. (2007). A germ line mutation in the death domain of DAPK-1 inactivates ERK-induced apoptosis. J Biol Chem 282:13791-13803. (Pubitemid 47100561)
29. Sun J, Misumi J, Shimaoka A, Aoki K, Esaki F (2001). Stomach cancer-related mortality. Eur J Cancer Prev 10:61-67. (Pubitemid 32200203)
30. Tang LP, Cho CH, Hui WM, Huang C, Chu KM, Xia HH, et al. (2006). An inverse correlation between interleukin-6 and select gene promoter methylation in patients with gastric cancer. Digestion 74:85-90. (Pubitemid 46192732)
31. Toyooka S, Toyooka KO, Miyajima K, Reddy JL, Toyota M, Sathyanarayana UG, et al. (2003). Epigenetic down-regulation of death-associated protein kinase in lung cancers. Clin Cancer Res 9:3034-3041. (Pubitemid 36993264)
32. Waki T, Tamura G, Sato M, Terashima M, Nishizuka S, Motoyama T (2003). Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci 94:360-364. (Pubitemid 36626369)